2026
Chitosan-Saponin-Bentonite Nanocomposites Prevent Doxorubicin-Induced Cardiovascular Toxicity by Inhibiting Oxidative Stress and ApoptosisCurrent Vascular Pharmacology, Chemotherapy-induced cardiotoxicity and mitigation
Active, last published 2026
In chemotherapy-induced cardiotoxicity and mitigation
Amel Mahmoud
Soliman
Scholar“Research focused on Chemotherapy-induced cardiotoxicity and mitigation and adjacent fields.”
Cairo UniversityEgypt
Claim Your Profile0
H-index
0
Citations
Amel has not officially claimed their profile. If you are Amel, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
01 · About the work
What I study
mel Mahmoud Soliman is a researcher working on Chemotherapy-induced cardiotoxicity and mitigation. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Amel's work has been cited 0 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
05 · Research focus
Topics
Chemotherapy-induced cardiotoxicity and mitigation×1Chemotherapy-induced organ toxicity mitigation×1Silymarin and Mushroom Poisoning×1
06 · Where I am
Affiliations
CurrentlyCairo University, Egypt
07 · Selected work
Recent publications
Are you Amel?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
No commitment required